FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Alan Reynolds

Research Profile

Procedures

Microbial Sensitivity Tests

Living Beings

Chemicals & Drugs

Geographic Areas

Great Britain

Activities & Behaviors

Cost Benefit Analysis

Concepts & Ideas

Co-author Network

Publications

TOP 3
Chris D Poole; Pete Conway; Alan Reynolds; Craig J Currie
The association between C-reactive protein and the likelihood of progression to joint replacement in people with rheumatoid arthritis: a retrospective observational study.
Roberta Ara; Alan Reynolds; Peter Conway
The cost-effectiveness of etanercept in patients with severe ankylosing spondylitis in the UK.
Nick Bansback; Roberta Ara; N Barkham; Alan Brennan; A D Fraser; Peter Conway; Alan Reynolds; P Emery
Estimating the cost and health status consequences of treatment with TNF antagonists in patients with psoriatic arthritis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Alan Reynolds (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: Chris D Poole; Pete Conway; Alan Reynolds; Craig J Currie
The association between C-reactive protein and the likelihood of progression to joint replacement in people with rheumatoid arthritis: a retrospective observational study.
BMC musculoskeletal disorders 2008;9():146.
2007: Roberta Ara; Alan Reynolds; Peter Conway
The cost-effectiveness of etanercept in patients with severe ankylosing spondylitis in the UK.
Rheumatology (Oxford, England) 2007;46(8):1338-44.
2006: Nick Bansback; Roberta Ara; N Barkham; Alan Brennan; A D Fraser; Peter Conway; Alan Reynolds; P Emery
Estimating the cost and health status consequences of treatment with TNF antagonists in patients with psoriatic arthritis.
Rheumatology (Oxford, England) 2006;45(8):1029-38.
2005: Peter H Howarth; K Suresh Babu; H S Arshad; L Lau; M Buckley; W McConnell; PA Beckett; Musa K Al-Ali; A Chauhan; Susan J Wilson; Alan Reynolds; Donna E Davies; Stephen T Holgate
Tumour necrosis factor (TNFalpha) as a novel therapeutic target in symptomatic corticosteroid dependent asthma.
Thorax 2005;60(12):1012-8.
2004: Alan Brennan; Nick Bansback; Alan Reynolds; Peter Conway
Modelling the cost-effectiveness of etanercept in adults with rheumatoid arthritis in the UK.
Rheumatology (Oxford, England) 2004;43(1):62-72.
2003: Alan J Lenox-Smith; Alan Reynolds
A double-blind, randomised, placebo controlled study of venlafaxine XL in patients with generalised anxiety disorder in primary care.
The British journal of general practice : the journal of the Royal College of General Practitioners 2003;53(495):772-7.
2001: Jan K Melichar; A Haida; C Rhodes; Alan Reynolds; David J Nutt; Andrea L Malizia
Venlafaxine occupation at the noradrenaline reuptake site: in-vivo determination in healthy volunteers.
Journal of psychopharmacology (Oxford, England) 2001;15(1):9-12.
2000: Andrea L Malizia; Jan K Melichar; C G Rhodes; A Haida; Alan Reynolds; T Jones; David J Nutt
Desipramine binding to noradrenaline reuptake sites in cardiac sympathetic neurons in man in vivo.
European journal of pharmacology 2000;391(3):263-7.
1997: Andrea L Malizia; J M Melichar; D J Brown; Roger Gunn; Alan Reynolds; Terry Jones; David J Nutt
Demonstration of clomipramine and venlafaxine occupation at serotonin reuptake sites in man in vivo.
Journal of psychopharmacology (Oxford, England) 1997;11(3):279-81.
1981: Alan Reynolds
The activity of nitro-compounds against Bacteroides fragilis is related to their electron affinity.
The Journal of antimicrobial chemotherapy 1981;8(2):91-9.
1980: J Cooper; W Brumfitt; J M Hamilton-Miller; Alan Reynolds
The role of periurethral colonization in the aetiology of recurrent urinary infection in women.
British journal of obstetrics and gynaecology 1980;87(12):1145-51.
1979: Alan Reynolds
Antibacterial activity and electron affinity of nitro-heterocyclic compounds [proceedings].
The Journal of pharmacy and pharmacology 1979;31 Suppl():29P.
1978: J M Hamilton-Miller; W Brumfitt; Alan Reynolds
Cefotoxime (HR 756) a new cephalosporin with exceptional broad-spectrum activity in vitro.
The Journal of antimicrobial chemotherapy 1978;4(5):437-44.
1977: Alan Reynolds; J M Hamilton-Miller; W Brumfitt
Discrepant behaviour of clotrimazole against Bacteroides fragilis in liquid and solid media.
The Journal of antimicrobial chemotherapy 1977;3(6):622-4.
1977: J M Hamilton-Miller; D W Kerry; Alan Reynolds; W Brumfitt
Two new bioassay techniques for nitrofurans: Bacteroides fragilis and rec-Escherichia coli as indicator strains.
Chemotherapy 1977;23(4):236-42.
1976: Alan Reynolds; J M Hamilton-Miller; W Brumfitt
Diminished effect of gentamicin under anaerobic or hypercapnic conditions.
Lancet 1976;1(7957):447-9.
1975: Alan Reynolds; J M Hamilton-Miller; W Brumfitt
A comparison of the in vitro activity of metronidazole, tinidazole, and nimorazole against Gram-negative anaerobic bacilli.
Journal of clinical pathology 1975;28(10):775-8.
1975: W Brumfitt; Alan Reynolds; J M Hamilton-Miller
Letter: Activity of nitrofurantoin and nifuratel against anaerobic gram-negative bacilli.
Lancet 1975;1(7904):460.
1974: J M Hamilton-Miller; Alan Reynolds; W Brumfitt
Letter: Apparent emergence of gentamicin-resistant Providencia stuartii during therapy with gentamicin.
Lancet 1974;2(7879):527.